These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 20393304)

  • 1. Impact of gene patents and licensing practices on access to genetic testing for long QT syndrome.
    Angrist M; Chandrasekharan S; Heaney C; Cook-Deegan R
    Genet Med; 2010 Apr; 12(4 Suppl):S111-54. PubMed ID: 20393304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of gene patents and licensing practices on access to genetic testing for cystic fibrosis.
    Chandrasekharan S; Heaney C; James T; Conover C; Cook-Deegan R
    Genet Med; 2010 Apr; 12(4 Suppl):S194-211. PubMed ID: 20393308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of gene patents and licensing practices on access to genetic testing for hearing loss.
    Chandrasekharan S; Fiffer M
    Genet Med; 2010 Apr; 12(4 Suppl):S171-93. PubMed ID: 20393307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of gene patents and licensing practices on access to genetic testing for inherited susceptibility to cancer: comparing breast and ovarian cancers with colon cancers.
    Cook-Deegan R; DeRienzo C; Carbone J; Chandrasekharan S; Heaney C; Conover C
    Genet Med; 2010 Apr; 12(4 Suppl):S15-38. PubMed ID: 20393305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of gene patents and licensing practices on access to genetic testing for hereditary hemochromatosis.
    Chandrasekharan S; Pitlick E; Heaney C; Cook-Deegan R
    Genet Med; 2010 Apr; 12(4 Suppl):S155-70. PubMed ID: 20393306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of patents on the development of genome-based clinical diagnostics: an analysis of case studies.
    Pierce BL; Carlson CS; Kuszler PC; Stanford JL; Austin MA
    Genet Med; 2009 Mar; 11(3):202-9. PubMed ID: 19367193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of gene patents and licensing practices on access to genetic testing for Alzheimer disease.
    Skeehan K; Heaney C; Cook-Deegan R
    Genet Med; 2010 Apr; 12(4 Suppl):S71-82. PubMed ID: 20393312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gene patent controversy on Twitter: a case study of Twitter users' responses to the CHEO lawsuit against Long QT gene patents.
    Du L; Kamenova K; Caulfield T
    BMC Med Ethics; 2015 Aug; 16():55. PubMed ID: 26302779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene patents still alive and kicking: their impact on provision of genetic testing for long QT syndrome in the Canadian public health-care system.
    Ali-Khan SE; Gold ER
    Genet Med; 2017 Nov; 19(11):1253-1259. PubMed ID: 28492533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene patenting and licensing: the role of academic researchers and advocacy groups.
    Ledbetter DH
    Genet Med; 2008 May; 10(5):314-9. PubMed ID: 18496028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinocerebellar ataxia: patient and health professional perspectives on whether and how patents affect access to clinical genetic testing.
    Powell A; Chandrasekharan S; Cook-Deegan R
    Genet Med; 2010 Apr; 12(4 Suppl):S83-S110. PubMed ID: 20393313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of gene patents and licensing practices on access to genetic testing and carrier screening for Tay-Sachs and Canavan disease.
    Colaianni A; Chandrasekharan S; Cook-Deegan R
    Genet Med; 2010 Apr; 12(4 Suppl):S5-S14. PubMed ID: 20393311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene patents and licensing: case studies prepared for the Secretary's Advisory Committee on Genetics, Health, and Society.
    Cook-Deegan R; Heaney C
    Genet Med; 2010 Apr; 12(4 Suppl):S1-2. PubMed ID: 20393303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patenting and licensing in genetic testing.
    ESHG Working Party on Patenting and Licensing
    Eur J Hum Genet; 2008 Apr; 16(4):405-11. PubMed ID: 18354424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of gene patents on diagnostic testing: a new patent landscaping method applied to spinocerebellar ataxia.
    Berthels N; Matthijs G; Van Overwalle G
    Eur J Hum Genet; 2011 Nov; 19(11):1114-21. PubMed ID: 21811306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do patents impede the provision of genetic tests in Australia?
    Nicol D; Liddicoat J
    Aust Health Rev; 2013 Jun; 37(3):281-5. PubMed ID: 23702081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene Patents in Canada: Is There a New Legal Landscape?
    Bonter KJ; De Luca C; Guerrini CJ
    Mol Diagn Ther; 2018 Apr; 22(2):149-155. PubMed ID: 29236230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
    Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of patenting on DNA diagnostic practice.
    Matthijs G; Hodgson S
    Clin Med (Lond); 2008 Feb; 8(1):58-60. PubMed ID: 18335671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patenting and licensing in genetic testing: recommendations of the European Society of Human Genetics.
    Aymé S; Matthijs G; Soini S;
    Eur J Hum Genet; 2008 May; 16 Suppl 1():S10-9. PubMed ID: 18432281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.